Control Bionics Ltd. (CBL)
ASX ASX Primary Summary
Control Bionics Ltd. (CBL) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Control Bionics Ltd. ever had a stock split?
Control Bionics Ltd. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Jeremy E. Steele CEO | ASX Exchange | AU0000114183 ISIN |
| Australia Country | - Employees | - Last Dividend | 13 Nov 2023 Last Split | - IPO Date |
Overview
Control Bionics Limited is a pioneering company deeply involved in the research, development, and commercialization of assistive communications technology systems. It operates mainly in Australia and North America, serving individuals who face speech and movement difficulties. Established in 2005 and initially known as Control Bionics Holdings Pty Limited, the company underwent a name change to Control Bionics Limited in September 2020. With its headquarters based in Camberwell, Australia, Control Bionics is dedicated to enhancing the lives of its users through innovative technology solutions.
Products and Services
NeuroNode Trilogy and NeuroNode3 Systems: These systems offer individuals with speech and movement impairments the ability to control a computer for various purposes such as speech generation, electronic communications, entertainment, and external device control. These systems are innovatively designed to recognize and interpret bioelectric signals or spatial movements.
Cosmos Connect: A compact and portable control device that works in conjunction with a Windows display device. Cosmos Connect is aimed at providing its users with enhanced accessibility and ease of interaction with technology.
NeuroNode: This wireless and wearable sensor serves as a bridge for users to access their technology through bioelectric signals or physical movements. Its versatility and ease of use make it a key component of Control Bionics' assistive technology ecosystem.
Uno Touch: Designed as a speech-generating device, Uno Touch facilitates communication for individuals with speech impairments, offering them a voice through technology. It’s tailored for ease of use and effectiveness.
NeuroNode Duo: An advancement in the NeuroNode technology, this wireless sensor further simplifies interaction with technology by capturing a broader spectrum of user inputs through bioelectric signals and movements.
Eye Gaze Duo: This innovative product allows users to control a computer mouse with their eyes, opening up new avenues for interaction and control for individuals who may have severe movement restrictions.
